Repligen

RGEN

Repligen is an American company devoted to the development and production of materials used in the manufacture of biological drugs.2014 The company is based in Waltham, Massachusetts,2014 and incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of February 2014, Repligen employed 116 people, about 50% of these based in Sweden.

Repligen has been a target of short sellers for a while. The current short interest of 11.72% is significantly above the average of the last 12 months (8.59%).